Covered recipient · General Payments record
MEAGAN A HOLCOMB
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$2,533.16
- Reported across 54 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $842.68 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| EMD Serono, Inc. | $407.88 | 4 |
| E.R. Squibb & Sons, L.L.C. | $124.99 | 1 |
| Neurocrine BioSciences, Inc. | $109.70 | 1 |
| Neurelis, Inc. | $41.83 | 2 |
| TG THERAPEUTICS, INC. | $31.41 | 1 |
| Aucta Pharmaceuticals, Inc. | $24.56 | 2 |
| Amneal Pharmaceuticals LLC | $22.27 | 1 |
| Lundbeck LLC | $22.20 | 1 |
| UCB, Inc. | $22.19 | 1 |
| Alexion Pharmaceuticals, Inc. | $21.02 | 1 |
| PFIZER INC. | $14.63 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Alexion Pharmaceuticals, Inc. | $21.02 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1094039372 | CMS |
| Amneal Pharmaceuticals LLC | $22.27 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139211338 | CMS |
| Aucta Pharmaceuticals, Inc. | $11.61 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147907254 | CMS |
| Aucta Pharmaceuticals, Inc. | $12.95 | 12/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147907794 | CMS |
| E.R. Squibb & Sons, L.L.C. | $124.99 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101748884 | CMS |
| EMD Serono, Inc. | $87.04 | 06/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120245861 | CMS |
| EMD Serono, Inc. | $87.15 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120255427 | CMS |
| EMD Serono, Inc. | $83.69 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120274268 | CMS |
| EMD Serono, Inc. | $150.00 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120278406 | CMS |
| Lundbeck LLC | $22.20 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146035954 | CMS |
| Neurelis, Inc. | $23.77 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145665022 | CMS |
| Neurelis, Inc. | $18.06 | 11/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145665024 | CMS |
| Neurocrine Biosciences, Inc. | $109.70 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150924742 | CMS |
| PFIZER INC. | $14.63 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131174464 | CMS |
| TG Therapeutics, Inc. | $31.41 | 02/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136873359 | CMS |
| UCB, Inc. | $22.19 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143358268 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.